These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 9556603

  • 21. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
    Chen PE, Geballe MT, Katz E, Erreger K, Livesey MR, O'Toole KK, Le P, Lee CJ, Snyder JP, Traynelis SF, Wyllie DJ.
    J Physiol; 2008 Jan 01; 586(1):227-45. PubMed ID: 17962328
    [Abstract] [Full Text] [Related]

  • 22. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.
    Mol Pharmacol; 1996 Dec 01; 50(6):1541-50. PubMed ID: 8967976
    [Abstract] [Full Text] [Related]

  • 23. Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site.
    Grimwood S, Le Bourdellès B, Whiting PJ.
    J Neurochem; 1995 Feb 01; 64(2):525-30. PubMed ID: 7830044
    [Abstract] [Full Text] [Related]

  • 24. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Buller AL, Larson HC, Morrisett RA, Monaghan DT.
    Mol Pharmacol; 1995 Oct 01; 48(4):717-23. PubMed ID: 7476899
    [Abstract] [Full Text] [Related]

  • 25. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.
    Williams K, Chao J, Kashiwagi K, Masuko T, Igarashi K.
    Mol Pharmacol; 1996 Oct 01; 50(4):701-8. PubMed ID: 8863813
    [Abstract] [Full Text] [Related]

  • 26. Expression and initial characterization of a soluble glycine binding domain of the N-methyl-D-aspartate receptor NR1 subunit.
    Ivanovic A, Reiländer H, Laube B, Kuhse J.
    J Biol Chem; 1998 Aug 07; 273(32):19933-7. PubMed ID: 9685327
    [Abstract] [Full Text] [Related]

  • 27. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM, Huettner JE, Guastella J, Keana JF, Weber E.
    Mol Pharmacol; 1995 Mar 07; 47(3):568-81. PubMed ID: 7700254
    [Abstract] [Full Text] [Related]

  • 28. Preferential co-assembly of recombinant NMDA receptors composed of three different subunits.
    Wafford KA, Bain CJ, Le Bourdelles B, Whiting PJ, Kemp JA.
    Neuroreport; 1993 Sep 30; 4(12):1347-9. PubMed ID: 7903167
    [Abstract] [Full Text] [Related]

  • 29. Ethanol inhibition of N-methyl-D-aspartate receptors is reduced by site-directed mutagenesis of a transmembrane domain phenylalanine residue.
    Ronald KM, Mirshahi T, Woodward JJ.
    J Biol Chem; 2001 Nov 30; 276(48):44729-35. PubMed ID: 11572853
    [Abstract] [Full Text] [Related]

  • 30. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
    Becker J, Li Z, Noe CR.
    Eur J Biochem; 1998 Sep 01; 256(2):427-35. PubMed ID: 9760184
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
    Madry C, Mesic I, Bartholomäus I, Nicke A, Betz H, Laube B.
    Biochem Biophys Res Commun; 2007 Mar 02; 354(1):102-8. PubMed ID: 17214961
    [Abstract] [Full Text] [Related]

  • 34. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
    Zhong J, Gribkoff VK, Molinoff PB.
    Mol Pharmacol; 1996 Sep 02; 50(3):631-8. PubMed ID: 8794904
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
    Reynolds IJ.
    J Neurochem; 1994 Jan 02; 62(1):54-62. PubMed ID: 7903355
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
    Chen N, Moshaver A, Raymond LA.
    Mol Pharmacol; 1997 Jun 02; 51(6):1015-23. PubMed ID: 9187268
    [Abstract] [Full Text] [Related]

  • 39. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J, Kim C, Yeom HD, Nguyen KVA, Eom S, Lee S, Jung JH, Lee JH, Kim SH, Kim IK, Lee JH.
    Pharmacol Rep; 2020 Apr 02; 72(2):472-480. PubMed ID: 32048268
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
    Smothers CT, Woodward JJ.
    J Pharmacol Exp Ther; 2007 Aug 02; 322(2):739-48. PubMed ID: 17502428
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.